Stay updated on ABP 798 vs. Rituximab in RA Clinical Trial

Sign up to get notified when there's something new on the ABP 798 vs. Rituximab in RA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP 798 vs. Rituximab in RA Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record describes Amgen’s completed 311-participant trial comparing ABP 798 with U.S. and E.U. rituximab formulations for moderate to severe rheumatoid arthritis. It also provides study outcomes, participant eligibility and locations, and links and terms for sharing individual-level data and accessing study documents.
    Difference
    97%
    Check dated 2026-11-08T14:19:42.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:37:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-25T14:40:25.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T14:59:33.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:24:06.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study record now displays a 403 Forbidden error, blocking access to the page content. This replaces the study details and navigation with an access-denied message.
    Difference
    21%
    Check dated 2026-09-20T08:51:50.000Z thumbnail image

Stay in the know with updates to ABP 798 vs. Rituximab in RA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP 798 vs. Rituximab in RA Clinical Trial page.